KPRXKIORA PHARMACEUTICALS INC

Nasdaq kiorapharma.com


$ 0.68 $ 0.09 (14.41 %)    

Thursday, 28-Mar-2024 12:56:29 EDT
QQQ $ 443.93 $ -0.82 (-0.18 %)
DIA $ 397.72 $ 0.20 (0.05 %)
SPY $ 523.07 $ -0.10 (-0.02 %)
TLT $ 94.55 $ -0.08 (-0.08 %)
GLD $ 205.72 $ 2.62 (1.29 %)
$ 0.706
$ 0.62
$ 0.00 x 0
$ 0.00 x 0
$ 0.62 - $ 0.68
$ 0.46 - $ 5.25
606,030
na
3.42M
$ 0.77
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 03-25-2024 12-31-2023 10-K
2 11-09-2023 09-30-2023 10-Q
3 08-08-2023 06-30-2023 10-Q
4 05-09-2023 03-31-2023 10-Q
5 03-23-2023 12-31-2022 10-K
6 11-09-2022 09-30-2022 10-Q
7 08-12-2022 06-30-2022 10-Q
8 07-08-2022 03-31-2022 10-Q
9 04-15-2022 12-31-2021 10-K
10 11-15-2021 09-30-2021 10-Q
11 08-12-2021 06-30-2021 10-Q
12 05-12-2021 03-31-2021 10-Q
13 03-25-2021 12-31-2020 10-K
14 11-09-2020 09-30-2020 10-Q
15 08-06-2020 06-30-2020 10-Q
16 05-06-2020 03-31-2020 10-Q
17 03-04-2020 12-31-2019 10-K
18 11-07-2019 09-30-2019 10-Q
19 08-08-2019 06-30-2019 10-Q
20 05-08-2019 03-31-2019 10-Q
21 03-01-2019 12-31-2018 10-K
22 11-13-2018 09-30-2018 10-Q
23 08-03-2018 06-30-2018 10-Q
24 05-11-2018 03-31-2018 10-Q
25 03-02-2018 12-31-2017 10-K
26 11-14-2017 09-30-2017 10-Q
27 08-04-2017 06-30-2017 10-Q
28 05-05-2017 03-31-2017 10-Q
29 02-23-2017 12-31-2016 10-K
30 11-01-2016 09-30-2016 10-Q
31 08-10-2016 06-30-2016 10-Q
32 05-13-2016 03-31-2016 10-Q
33 03-30-2016 12-31-2015 10-K
34 11-12-2015 09-30-2015 10-Q
35 08-12-2015 06-30-2015 10-Q
36 05-15-2015 03-31-2015 10-Q
37 03-31-2015 12-31-2014 10-K
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 kiora-pharmaceuticals-to-present-additional-data-from-its-abacus-1-trial-of-kio-301-in-retinitis-pigmentosa-at-arvo-2024-annual-meeting

https://www.newsfilecorp.com/release/203326

 hc-wainwright--co-maintains-buy-on-kiora-pharmaceuticals-maintains-2-price-target

HC Wainwright & Co. analyst Yi Chen maintains Kiora Pharmaceuticals (NASDAQ:KPRX) with a Buy and maintains $2 price target.

 hc-wainwright--co-maintains-buy-on-kiora-pharmaceuticals-adjusts-price-target-to-2

HC Wainwright & Co. analyst Yi Chen maintains Kiora Pharmaceuticals (NASDAQ:KPRX) with a Buy, adjusts target to $2 from ...

 why-skechers-shares-are-trading-lower-by-around-7-here-are-other-stocks-moving-in-fridays-mid-day-session

Shares of Skechers U.S.A., Inc. (NYSE: SKX) shares fell during Friday’s session after the company reported mixed fourth-quarte...

 why-meta-shares-are-trading-higher-by-over-16-here-are-20-stocks-moving-premarket

Shares of Meta Platforms, Inc. (NASDAQ: META) rose sharply in today’s pre-market trading as the company reported upbeat fourth-...

 why-ch-robinson-shares-are-trading-lower-by-over-12-here-are-other-stocks-moving-in-thursdays-mid-day-session

Shares of C.H. Robinson Worldwide, Inc. (NASDAQ: CHRW) fell sharply during Thursday’s session after the company reported worse-...

 whats-going-on-with-kiora-pharmaceuticals-stock

Kiora Pharmaceuticals also entered into a securities purchase agreement with certain institutional investors, pursuant to which...

 why-nextracker-shares-are-trading-higher-by-around-20-here-are-20-stocks-moving-premarket

Shares of Nextracker Inc. (NASDAQ: NXT) rose sharply during today’s pre-market trading after the company reported better-than-...

 kiora-pharmaceuticals-announced-private-placement-of-up-to-45m

- Kiora Pharmaceuticals, Inc. (NASDAQ:KPRX) ("Kiora" or the "Company"), a clinical-stage biopharmaceutical comp...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION